Introduction
Many pharmaceutical companies assume there's one "drug import licence" that gets a product through UK customs and onto a pharmacy shelf. There isn't.
UK medicine imports sit under a patchwork of permissions from the MHRA, the Home Office and HMRC. Which ones apply depends on the medicine, its source country, its destination and what you actually plan to do with it once it arrives.
This guide is written for pharmaceutical companies, wholesalers, distributors, overseas manufacturers and any business planning to import medicines commercially into the UK. Personal-use imports follow separate, much narrower rules covered briefly below.
Getting the classification wrong is expensive. Importing, storing, wholesaling, repackaging and transporting medicines can each trigger different licensing requirements.
This article walks through licence types, eligibility, application documents, the Great Britain versus Northern Ireland distinction, post-approval duties and the mistakes that trip up applicants most often.
Key Takeaways
- A "drug import licence" is not one universal permit; authorisation depends on the medicine, route and destination
- Commercial importers need a wholesale or manufacturing/import authorisation plus a marketing authorisation route
- Controlled drugs, unlicensed medicines and parallel imports each carry separate rules and exemptions
- Customs clearance, GDP compliance and recall readiness continue after a licence is granted
What Is a Drug Import Licence in the UK and Why Is It Required?
There's no single generic licence that covers every medicine import into the UK. Instead, the Human Medicines Regulations 2012 create several distinct permissions, each covering a different activity.
| Permission | What it actually authorises |
|---|---|
| Wholesale Dealer's Authorisation (WDA(H)) | Wholesale import, storage and supply of medicines, typically from an approved country into Great Britain |
| Manufacturer/Importer Authorisation (MIA) | Manufacturing, assembly, repackaging and import from countries not on the approved list, with Qualified Person batch release |
| Marketing Authorisation (MA) | Whether a specific product may be placed on the UK market at all |
A customs declaration is a fourth, entirely separate matter. It lets goods move across the border — it doesn't make an unlicensed medicine lawful to sell. Confusing "cleared customs" with "authorised for supply" is one of the most common and costly mistakes importers make.
GB and Northern Ireland Are Not the Same Route
Requirements diverge between Great Britain and Northern Ireland. Under the Windsor Framework, changes that took effect on 1 January 2025 mean the MHRA authorises medicines UK-wide, and UK packs must carry a clearly legible "UK Only" label.
Medicines moving from the EU into Northern Ireland don't require a Responsible Person (import), unlike qualifying Great Britain imports.
Check the MHRA's wholesalers' and manufacturers' guidance following the Windsor Framework before assuming a Great Britain process applies to a Northern Ireland-bound shipment.
Commercial Import vs. Other Routes
An exemption for one route never authorises resale under another. Each non-wholesale path has its own rules:
- Named-patient "specials" imports
- Clinical trial supply
- Parallel importation
- Personal importation (far more restrictive than most people assume) Full MHRA guidance on the legal framework is available in its official import guidance for human medicines.
UK Drug Import Licence Requirements and Application Process
Before touching an application form, classify the shipment. You need clear answers on:
- Human or veterinary medicine
- Authorised (has a UK marketing authorisation) or unlicensed product
- Controlled or non-controlled substance
- Commercial or personal import
- Source country and exact UK destination
Wholesale or Manufacturing Authorisation?
A WDA(H) (Wholesale Distribution Authorisation for human medicines) generally suits businesses importing, storing and supplying medicines that already have batch release and marketing authorisation, sourced from an approved country. If your activity involves manufacture, assembly, repackaging or importing from a country outside the approved list, you'll likely need a manufacturer's licence with Qualified Person (QP) release before the batch can be sold.
Responsible Person arrangements differ by route:
| Role | Responsibility |
|---|---|
| Responsible Person (RP) | Oversees GDP compliance for the wholesale operation |
| Responsible Person (import) (RPi) | Verifies QP certification for qualifying GB imports from approved countries |
| Qualified Person (QP) | Certifies batches imported under a Manufacturer's Import Authorisation (MIA) before release |
Controlled Drugs Need a Separate Permit
Home Office rules sit on top of any MHRA permission. If the substance falls under the Misuse of Drugs Regulations 2001, you'll usually need a domestic controlled-drugs licence first, then a shipment-specific import permit.
According to Home Office guidance on controlled drugs import and export licences, these single-use licences are issued per shipment and are typically valid for three months.
Other special categories worth flagging early:
- Active substances — require separate MHRA registration
- Biologicals (vaccines, blood products) — may need independent batch release, not just wholesale certification
- Veterinary medicines — regulated by the VMD, not the MHRA
- Radioactive medicinal products — may trigger separate environmental permitting
The Application Workflow
- Confirm classification — product type, route, source country, destination
- Identify the right authorisation — WDA(H), MIA, or both, plus any Home Office requirement
- Prepare evidence — company, premises, supply chain, product, storage, transport, quality system, responsible personnel
- Submit and pay — through the current MHRA or Home Office portal, responding promptly to inspection requests
Treat published timelines as planning guides, not guarantees. MHRA guidance references a 90-working-day process; Home Office guidance cites roughly 10 working days for valid controlled-drug applications.
Document checklist to prepare:
- Company and premises details, existing licences, Responsible Person information
- Product data, marketing authorisation details, source-country authorisation, manufacturer records
- GMP/GDP evidence, quality agreements, storage and transport controls, recall procedures
- EORI number, commodity code, invoice, packing list, transport documents
- Controlled-drug permits or certificates, where applicable
Overseas manufacturers and UK importers should contractually allocate who maintains records, manages deviations and communicates with the MHRA. Ambiguity here is where recalls go wrong.
What Happens After Approval?
Getting the licence is the start, not the finish line. From here, compliance runs continuously through:
- Approved supplier checks
- Shipment and border entry
- Receipt, quarantine or release
- Storage, wholesale supply and final distribution
GDP Doesn't Stop at the Warehouse Door
MHRA's Good Distribution Practice expectations cover premises, temperature control, security, transport, traceability and recall systems. A temperature excursion during transit is a quality deviation, not just a delivery delay.
MHRA's own inspectors have flagged a practical gap in the aviation and marine sectors: wholesalers often can't evidence where stock sat at intermediate hand-offs, or how they'd contact a vessel mid-transit during a recall. Map custody and recall contacts across every hand-off before your first consignment moves, not after something goes wrong.
Ongoing Safety and Recordkeeping Duties
- Report suspected adverse reactions through the appropriate channel, including the Yellow Card scheme
- Notify the MHRA of suspected defects, withdrawals or shortages where relevant
- Maintain auditable records for inspections, renewals and variations
- Reassess compliance whenever premises, suppliers, products or routes change
Customs Is a Separate System, Always
Clearing customs never confirms medicine-specific compliance. You'll still need to confirm the correct commodity code, customs value, origin, import declaration and duty/VAT treatment with HMRC or a customs specialist, independently of your MHRA or Home Office status.
Running UK pharmaceutical imports alongside wider international operations adds a separate workstream: accounting, entity structuring and cross-border compliance sit outside the MHRA process.
VJM Global helps businesses coordinate business setup, accounting and multi-market compliance, including India-related operations. Specialist MHRA or Home Office licensing advice should always come from a regulatory specialist, not a general compliance partner.
Common Issues and When a Drug Import Licence May Not Be Enough
A surprising number of shipments stall not because a licence was refused, but because someone assumed the wrong thing was sufficient.
Misconceptions that cause delays:
| Assumption | Reality |
|---|---|
| "We have a UK company and an EORI number" | Neither authorises medicine importation or supply on its own |
| "Our supplier has foreign manufacturing approval" | Doesn't automatically satisfy UK importer, MA or GDP requirements |
| "We hold a wholesale dealer's licence" | Doesn't permit marketing an unlicensed medicine or importing controlled drugs without extra permission |
| "This is a personal-use exemption" | Never permits resale, advertising or commercial distribution |
Applications and shipments most often fail because of:
- Incorrect product classification at the outset
- Missing marketing authorisation evidence
- Weak or undefined Responsible Person arrangements
- Inadequate temperature control documentation
- Incomplete supplier qualification records
- Inconsistent labelling or customs paperwork
Certain situations call for specialist regulatory advice before you commit to a shipment date:
- Controlled drugs
- Unlicensed medicines
- Parallel imports
- Clinical-trial products
- Biologicals
- Shipments bound for Northern Ireland or destined for UK repackaging
Regulations, guidance and transitional arrangements change. Always confirm current requirements directly with the MHRA, Home Office or HMRC before you apply or ship.
Conclusion
UK drug import compliance depends on the medicine, the importer's activities, the route, the source country and the destination. It is never covered by a single generic licence. Classify the product first, identify every authorisation that applies, prepare quality and customs evidence in parallel, confirm the route with the relevant authority, and keep compliance running well after approval.
Specialist regulatory advice is essential before shipping anything controlled, unlicensed, parallel-imported or Northern Ireland-bound.
Businesses that also need wider international structuring, such as FEMA advisory, bookkeeping and compliance for India-linked operations, can work with VJM Global on the broader financial and compliance side. That support is distinct from medicine-specific licensing.
Frequently Asked Questions
What is a drug import licence in the UK?
It's a general term for the permissions needed to import and supply medicines commercially. Depending on the product and route, this can involve MHRA wholesale or manufacturing authorisations, marketing authorisation status, or Home Office controlled-drug permissions.
How do I obtain a drug import licence in the UK?
Classify your product and route, identify the relevant authority, and prepare company, product, premises and supply-chain evidence. Submit through the current official MHRA or Home Office application route and respond to any inspection queries.
Do I need to register with the MHRA to import drugs into the UK?
Most commercial medicine imports require some form of MHRA authorisation, though the exact requirement depends on the product and activity. MHRA registration is distinct from HMRC customs registration and separate Home Office controlled-drug permissions.
Do I need a wholesale dealer's licence to import medicines into the UK?
A WDA(H) can cover importing, storing and supplying medicines that already hold marketing authorisation, typically from approved countries. Imports from other countries, or activities involving manufacture and repackaging, often need a manufacturer/importer authorisation instead.
What licence is required to import controlled drugs into the UK?
Controlled drugs need a separate Home Office permission on top of any MHRA authorisation. The exact requirement depends on the drug's schedule, so check current Home Office guidance before shipping.
Can I import medicines into the UK for personal use without a drug import licence?
Limited personal-use imports are treated differently from commercial ones, but controlled drugs and certain other products still need extra permissions. Personal-use exemptions never cover resale or distribution.
